Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 27;132(3):941-3.
doi: 10.1021/ja9082864.

Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate alpha-helix

Laura K Henchey  1 , Swati Kushal, Ramin Dubey, Ross N Chapman, Bogdan Z Olenyuk, Paramjit S Arora
Affiliations

Inhibition of hypoxia inducible factor 1-transcription coactivator interaction by a hydrogen bond surrogate alpha-helix

Laura K Henchey et al. J Am Chem Soc. .

Abstract

Designed ligands that inhibit hypoxia-inducible gene expression could offer new tools for genomic research and, potentially, drug discovery efforts for the treatment of neovascularization in cancers. We report a stabilized alpha-helix designed to target the binding interface between the C-terminal transactivation domain (C-TAD) of hypoxia-inducible factor 1alpha (HIF-1alpha) and cysteine-histidine rich region (CH1) of transcriptional coactivator CBP/p300. The synthetic helix disrupts the structure and function of this complex, resulting in a rapid downregulation of two hypoxia-inducible genes (VEGF and GLUT1) in cell culture.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Transcription of hypoxia inducible genes is controlled by the interaction of DNA-bound HIF-1α/ARNT heterodimer with transcription coactivator CBP/p300. (b) Competitive inhibition of the HIF-1α C-TAD complex with CBP/p300 CH1 domain leads to downregulation of VEGF transcription. (c) α-Helices from the C-TAD793–826 domain of HIF-1α bind to the cysteine-histidine rich 1 (CH1) region of CBP/p300. HIF-1α is shown in orange and yellow colors and CBP/p300 in green (PDB code 1L8C). (d) HBS α-helices feature a carbon-carbon bond in place of an N-terminal i and i+4 hydrogen bond.
Figure 2
Figure 2
(a) Circular dichroism spectra of HBS helices 1–3 and unconstrained peptide 4 in 10% TFE in phosphate buffered saline (pH 6.3). (b, c) Isothermal titration microcalorimetry analysis of HBS 2 binding to GST-p300. (b) Baseline-subtracted raw ITC data for injections of HBS 2 into a solution of the GST-p300 in Tris buffer at 25 °C. (c) Integration of titration signals (squares), caused by the binding of HBS 2 with GST-p300, fit to a single-site binding model curve (line).
Figure 3
Figure 3
(a) Inhibition of VEGF and glucose transporter 1 (GLUT1) gene expression with HBS helix 2 and peptide 4, after 12 h of incubation under hypoxia conditions, as measured by real time qRT-PCR in HeLa cells. *, P < 0.05, t-test. (b) Cell density and population doubling data for cultures treated with chetomin, HBS 2, and control peptide 4. 200 nM chetomin and 1 μM peptides (2 and 4) were used in the cell culture and cell viability assays. Control: cell culture medium only, vehicle: 0.1% DMSO in cell culture medium.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ptashne M, Gann A. Genes and signals. Cold Spring Harbor Laboratory Press; New York: 2002.
    1. Mapp AK, Ansari AZ. ACS Chem. Biol. 2007;2:62–75. - PubMed
    1. Buhrlage SJ, Bates CA, Rowe SP, Minter AR, Brennan BB, Majmudar CY, Wemmer DE, Al-Hashimi H, Mapp AK. ACS Chem. Biol. 2009;4:335–344. - PMC - PubMed
    2. Becerril J, Hamilton AD. Angew. Chem. Int. Ed. 2007;46:4471–4473. - PubMed
    3. Liu B, Alluri PG, Yu P, Kodadek T. J. Am. Chem. Soc. 2005;127:8254–8255. - PubMed
    4. Shimogawa H, Kwon Y, Mao Q, Kawazoe Y, Choi Y, Asada S, Kigoshi H, Uesugi M. J. Am. Chem. Soc. 2004;126:3461–3471. - PubMed
    1. Hirota K, Semenza GL. Crit. Rev. Oncol. Hematol. 2006;59:15–26. - PubMed
    1. Semenza GL. Nat. Rev. Cancer. 2003;3:721–732. - PubMed

Publication types

MeSH terms